small molecule design and development

DermaXon is a Montana-based drug discovery and development company founded in 2013 providing first-in-class drug candidates. It targets the brain-skin connection to discover and develop novel therapeutic strategies to treat life-threatening diseases and disorders such as pain, pruritus and genetic disorders of skin keratinization. Its core technology is based on the design and development of small molecules modulating multiple targets or inhibiting the degradation of endogenous molecules exhibiting polypharmacology.

Read more

drug discovery and developmentmedicinal chemistrymolecular biologyRNA sequencing